Skip to content

U-100 unit conversion

Tesamorelin calculator

Convert mass and volume to U-100 units. No dose is selected.

These are example numbers so you can see the math. Try yours. Change them to match the vial in your hand.

10U-100 units · 0.1 mL

25 mcg per unit · 2500 mcg/mL

How the calculator works, sources and review dates

Tesamorelin math uses the listed vial sizes on this card and the liquid you type. Concentration in mcg per mL is vial milligrams times 1000, divided by milliliters. A U-100 syringe has 100 marks per milliliter, so each unit is that concentration divided by 100. Example numbers so you can see the math: a 5 mg listing plus 2 mL of liquid. Change any number and the units change. Try the numbers. A research-market vial is not the same material used in a trial.

Editorial review 2026-10-09. source-curated; clinician review pending.

Units chart for listed Tesamorelin sizes

U-100 math for listed Tesamorelin sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
5 mg502516.7
10 mg1005033.3

What is Tesamorelin?

Approved-product evidence applies to that use only. Putting the tesamorelin name on a research vial does not extend Egrifta’s approval to general body-composition wellness. The catalog keeps those identities separate.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Product label

Approved product label

Adults with HIV-associated lipodystrophy and excess abdominal fat; not general weight loss.

Reported findings. Adults with HIV-associated lipodystrophy and excess abdominal fat; not general weight loss. Egrifta WR, for its labeled HIV-associated indication.

Nonresponse. Responses vary; no population guarantee.

Harms. Elevated IGF-1, glucose intolerance and fluid retention are label warnings.

Limits. Labeled preparation only; marketed variants do not inherit approval.

Preparation: Egrifta WR, for its labeled HIV-associated indication. Route: subcutaneous WR, not substitutable with SV

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

approved product. Egrifta WR, for its labeled HIV-associated indication.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

product specific. Adults with HIV-associated lipodystrophy and excess abdominal fat; not general weight loss.

Sport

prohibited. WADA S2 lists this GHRH analogue.

How long it lasts, how you store it, listed sizes

0.18333333333333332 hours. About eleven minutes for the labeled Egrifta WR formulation in healthy subjects; formulations differ.

Egrifta has carton storage. Research vials have whatever the seller printed. This chart uses 5 mg and 10 mg listings from the vendor file only.

Risks and mix-ups already on the record

  • Elevated IGF-1, glucose intolerance and fluid retention are label warnings.
  • Active malignancy and pregnancy are among labeled contraindications.
  • Growth-hormone effects may change clearance of drugs metabolized by CYP450; the label advises monitoring concomitant medicines.
  • Patients receiving glucocorticoid replacement may require clinician review.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Approved product label · checked 2026-10-09
  2. WADA prohibited list · checked 2026-10-09
  3. DailyMed search for tesamorelin / Egrifta · checked 2026-10-09
  4. Tesamorelin trial (PubMed 20554713) · checked 2026-10-09
  5. FDA Egrifta product information · checked 2026-10-09

Questions people ask

Is tesamorelin approved for general fat loss?

The cited approval is for Egrifta and HIV-related lipodystrophy. This page does not extend that use.

Why show a calculator if the approved product is a branded kit?

People also hold research-market vials and ask for unit math. The calculator never copies the Egrifta schedule.

How many units is a listed Tesamorelin vial after you add water?

Units = (amount in mcg ÷ (vial mg × 1000 ÷ water mL)) × 100 on a U-100 syringe. Enter the three numbers. The chart shows the same math for each listed vial size and 1, 2 or 3 mL of liquid.

Why flag amounts under 5 units?

A U-100 barrel is easy to misread below about 5 marks. That is a measuring warning. The page does not tell you to take more.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.